Stockreport

Candel Therapeutics Enters into $130 Million Term Loan Facility with Trinity Capital Inc.

Candel Therapeutics, Inc.  (CADL) 
PDF $50 million drawn down at closing, with access to up to an additional $80 millionStrengthens Company’s financial position; enables initiation of phase 3 clinical trial o [Read more]